Arafat Shabbir

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UA Pine Bluff

Also affiliated: Yale New Haven Hospital (2022–2023); Guthrie Foundation (2022); Mount Sinai Medical Center (2022); Columbia University (2022)

Unknown Researcher

2 h-index 6 pubs 25 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Arafat Shabbir's research focuses on cancer biology and treatment, with a particular emphasis on genetic alterations and therapeutic strategies. His work includes investigating the role of RET alterations in various cancers and exploring the efficacy of targeted therapies and immunotherapies. Shabbir has also contributed to the literature on specific cancer types, such as extranodal diffuse large B-cell lymphoma and neuroendocrine carcinomas.

His research extends to systematic reviews and meta-analyses of emerging treatment modalities. This includes evaluating CAR-T cell therapy for prostate cancer and assessing the outcomes of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer, as well as its efficacy in metastatic hormone-sensitive prostate cancer. Shabbir's publications also touch upon the incidence of Clostridioides difficile infection in stem cell transplant recipients.

Metrics

h-index: 2
Publications: 6
Citations: 25

Selected Publications

Role of CAR-T cell therapy in prostate cancer: A systematic review and meta-analysis. (2026)

Journal of Clinical Oncology DOI OpenAlex
Persistence of aggressive biology: Outcomes of <sup>177</sup> Lu-PSMA-617 in <i>BRCA</i> -altered mCRPC—Systematic review and meta-analysis. (2026)

Journal of Clinical Oncology DOI OpenAlex
Efficacy of Lu-PSMA–based treatment strategies in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. (2026)

Journal of Clinical Oncology DOI OpenAlex